Centene delivered strong Q4 2025 revenue growth, but results were weighed down by significant impairment charges, resulting in a GAAP net loss and negative earnings per share.

Centene Corporation posted a significant net loss for Q3 2025 due to a large goodwill impairment, despite seeing growth in revenue and adjusted EPS beating expectations.

Centene achieved significant revenue growth in Q2 2025 driven by PDP and Marketplace membership gains, but reported a net loss as rising medical costs and unfavorable risk adjustment changes pressured margins.

Centene saw significant top- and bottom-line growth in Q1 2025, with strong membership gains in the Marketplace and Medicare PDP segments, leading to an upward revision of full-year revenue guidance.

Centene Corporation announced its Q4 and full year 2024 financial results. The company reported Q4 total revenues of $40.805 billion and GAAP diluted EPS of $0.56. Despite industry headwinds, Centene demonstrated operational improvements and delivered on its financial commitments.

Centene Corporation announced its third quarter 2024 financial results, featuring adjusted diluted EPS of $1.62 and premium and service revenues of $36.9 billion. The company reaffirmed its 2024 adjusted diluted EPS guidance floor of greater than $6.80. Membership increased in Marketplace and Medicare Prescription Drug Plans. Centene executed capital deployment with $1.2 billion of share repurchases during the quarter.

Centene Corporation reported a 3% increase in premium and service revenues, reaching $36.0 billion, and an adjusted diluted EPS of $2.42, a 15% increase from Q2 2023. The company reaffirms its 2024 adjusted diluted EPS guidance floor of greater than $6.80. While Medicaid faces challenges, overall performance remains on track.

Centene Corporation reported a strong first quarter in 2024, with premium and service revenues reaching $36.3 billion. The company's adjusted diluted EPS was $2.26, up over 7% from the first quarter of 2023. Centene increased its full year adjusted diluted EPS guidance by $0.10 to greater than $6.80 and raised its full year premium and service revenue guidance by $1.0 billion.

Centene Corporation reported a total revenue of $39.46 billion and an adjusted diluted EPS of $0.45 for Q4 2023. The company's results were slightly ahead of previous guidance, driven by membership growth in the Marketplace business. The company is increasing its 2024 premium and service revenues guidance range by $2.5 billion to a range of $134.5 billion to $137.5 billion.

Centene Corporation announced its financial results for the third quarter ended September 30, 2023. The company reported adjusted diluted EPS of $2.00, up over 53% from $1.30 in the third quarter of 2022. It increased its 2023 full year adjusted diluted EPS guidance by $0.15 to at least $6.60 and reiterated its 2024 adjusted diluted EPS floor of greater than $6.60.

Centene Corporation announced its financial results for the second quarter ended June 30, 2023. The company reported adjusted diluted EPS of $2.10, up over 18% from the second quarter of 2022. Premium and service revenues were $34.8 billion. Centene increased its 2023 full year adjusted diluted EPS guidance by $0.05 to at least $6.45.

Centene Corporation announced strong first quarter results with premium and service revenues of $35.0 billion. Diluted EPS was $2.04, and adjusted diluted EPS was $2.11. The company increased its 2023 full year adjusted EPS guidance to at least $6.40 and updated its 2024 adjusted EPS target to greater than $6.60.

Centene Corporation reported a 9% increase in total revenues for Q4 2022, reaching $35.6 billion, driven by Medicaid and Medicare growth, and the acquisition of Magellan. However, the company experienced a GAAP diluted loss per share of $(0.38), while adjusted diluted EPS was $0.86. The company executed $1.4 billion in share repurchases during the quarter and increased its 2023 premium and service revenues guidance by $2.0 billion.

Centene Corporation reported strong third-quarter results, with total revenues up 11% year-over-year, driven by organic Medicaid and Medicare growth. The company raised its full-year adjusted diluted EPS guidance for the fourth time in 2022. The selection of a new PBM partner was a key milestone in the Value Creation Plan.

Centene Corporation's second quarter results showed a 16% increase in total revenues driven by organic Medicaid and Medicare growth. The company increased its full-year adjusted diluted EPS guidance by $0.05 to a range of $5.60 to $5.75. The diluted loss per share was $(0.29), impacted by a real estate impairment charge. Execution of the Value Creation Plan continued through real estate optimization, divestitures, and share repurchases.

Centene Corporation reported a strong first quarter in 2022, with total revenues of $37.2 billion, representing a 24% increase compared to the first quarter of 2021. The company's diluted EPS was $1.44, and the adjusted diluted EPS was $1.83. Centene has raised its total revenue and adjusted EPS guidance for the year.

Centene Corporation reported a 15% increase in total revenues for Q4 2021, reaching $32.6 billion, and diluted EPS of $1.01. The company's managed care membership increased by 1.1 million members compared to the previous year. Centene reiterates its 2022 Adjusted diluted EPS guidance of $5.30 to $5.50 and HBR guidance of 87.6% to 88.2%.

Centene Corporation reported strong third quarter results with total revenues of $32.4 billion, representing 11% growth compared to the third quarter of 2020, and a diluted EPS of $0.99 and adjusted diluted EPS of $1.26.

Centene Corporation announced its financial results for the second quarter ended June 30, 2021, reporting a diluted loss per share of $(0.92) and adjusted diluted earnings per share (EPS) of $1.25. Total revenues for the quarter were $31.0 billion, representing a 12% increase compared to the second quarter of 2020.

Centene Corporation announced its financial results for the first quarter ended March 31, 2021, reporting diluted earnings per share (EPS) of $1.19 and adjusted diluted EPS of $1.63. The company is increasing its full-year guidance, driven by the positive first quarter momentum.

Centene Corporation reported a net loss per share of $(0.02) for Q4 2020, while adjusted EPS was $0.46. Total revenues increased by 50% to $28.3 billion compared to Q4 2019, driven by the acquisition of WellCare and growth in Medicaid and Health Insurance Marketplace businesses. The company's managed care membership increased by 67% year-over-year to 25.5 million.

Centene Corporation reported a 53% increase in total revenues to $29.1 billion for the third quarter of 2020, driven by the WellCare acquisition and expansions. GAAP diluted EPS was $0.97, and adjusted diluted EPS was $1.26. The company is reinvesting a one-time risk corridor settlement into growth initiatives.

Centene Corporation reported a strong second quarter in 2020, with diluted EPS of $2.05 and adjusted diluted EPS of $2.40. The company's performance was driven by lower medical utilization due to the COVID-19 pandemic and solid execution by the team. Total revenues increased by 51% compared to the second quarter of 2019, reaching $27.7 billion.

Centene Corporation reported a 41% increase in total revenues, reaching $26.0 billion, driven by the acquisition of WellCare, growth in the Health Insurance Marketplace, and expansions in various states. Diluted EPS was $0.08, and Adjusted Diluted EPS was $0.86, with both figures negatively impacted by lower investment income and incremental senior note interest expense.

Centene Corporation reported a 14% increase in total revenues for Q4 2019, reaching $18.9 billion. Diluted EPS was $0.49, and adjusted diluted EPS was $0.73. The company's performance was driven by growth in the Health Insurance Marketplace and expansions in several states. Centene also completed its acquisition of WellCare in January 2020, expanding its government-sponsored healthcare programs.